ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ketorolac Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-36L5761
Home | Market Reports | Health| Health Conditions| Pain Management
Global Ketorolac Market Insights and Forecast to 2028
BUY CHAPTERS

Global Ketorolac Market Research Report 2025

Code: QYRE-Auto-36L5761
Report
September 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Femina Pharma
Fuisz Pharma
Allergan plc
Technical Chemicals & Products
Apotex Corporation
Sichuan Meida Kangjiale Pharmaceutical
Tianjin Hongri Pharmaceutical
Shandong New Era Pharmaceutical
Chengdu Better Pharmaceutical
Yongxin Pharmaceutical Industry
Technical Chemicals & Products

Ketorolac Market

The global market for Ketorolac was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.It"s analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis.12 Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.
North American market for Ketorolac is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Ketorolac is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Ketorolac in Postoperative Pain is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Ketorolac include Pfizer, Femina Pharma, Fuisz Pharma, Allergan, Technical Chemicals & Products, Apotex Corporation, Sichuan Meida Kangjiale Pharmaceutical, Tianjin Hongri Pharmaceutical, Shandong New Era Pharmaceutical, Chengdu Better Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ketorolac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketorolac.
The Ketorolac market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ketorolac market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ketorolac companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Ketorolac Market Report

Report Metric Details
Report Name Ketorolac Market
Segment by Type
  • Tablets
  • Injection
  • Eye Drops
  • Capsule
Segment by Application
  • Postoperative Pain
  • Acute Renal Colic
  • Biliary Colic
  • Toothache
  • And The Pain
  • Trigeminal Neuralgia
  • Cancer Visceral Pain
  • Seasonal Allergic Conjunctivitis
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Femina Pharma, Fuisz Pharma, Allergan, Technical Chemicals & Products, Apotex Corporation, Sichuan Meida Kangjiale Pharmaceutical, Tianjin Hongri Pharmaceutical, Shandong New Era Pharmaceutical, Chengdu Better Pharmaceutical, Yongxin Pharmaceutical Industry
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Ketorolac company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Ketorolac Market report?

Ans: The main players in the Ketorolac Market are Pfizer, Femina Pharma, Fuisz Pharma, Allergan, Technical Chemicals & Products, Apotex Corporation, Sichuan Meida Kangjiale Pharmaceutical, Tianjin Hongri Pharmaceutical, Shandong New Era Pharmaceutical, Chengdu Better Pharmaceutical, Yongxin Pharmaceutical Industry

What are the Application segmentation covered in the Ketorolac Market report?

Ans: The Applications covered in the Ketorolac Market report are Postoperative Pain, Acute Renal Colic, Biliary Colic, Toothache, And The Pain, Trigeminal Neuralgia, Cancer Visceral Pain, Seasonal Allergic Conjunctivitis, Other

What are the Type segmentation covered in the Ketorolac Market report?

Ans: The Types covered in the Ketorolac Market report are Tablets, Injection, Eye Drops, Capsule

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ketorolac Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablets
1.2.3 Injection
1.2.4 Eye Drops
1.2.5 Capsule
1.3 Market by Application
1.3.1 Global Ketorolac Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Postoperative Pain
1.3.3 Acute Renal Colic
1.3.4 Biliary Colic
1.3.5 Toothache
1.3.6 And The Pain
1.3.7 Trigeminal Neuralgia
1.3.8 Cancer Visceral Pain
1.3.9 Seasonal Allergic Conjunctivitis
1.3.10 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ketorolac Market Perspective (2020-2031)
2.2 Global Ketorolac Growth Trends by Region
2.2.1 Global Ketorolac Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Ketorolac Historic Market Size by Region (2020-2025)
2.2.3 Ketorolac Forecasted Market Size by Region (2026-2031)
2.3 Ketorolac Market Dynamics
2.3.1 Ketorolac Industry Trends
2.3.2 Ketorolac Market Drivers
2.3.3 Ketorolac Market Challenges
2.3.4 Ketorolac Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ketorolac Players by Revenue
3.1.1 Global Top Ketorolac Players by Revenue (2020-2025)
3.1.2 Global Ketorolac Revenue Market Share by Players (2020-2025)
3.2 Global Ketorolac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Ketorolac Revenue
3.4 Global Ketorolac Market Concentration Ratio
3.4.1 Global Ketorolac Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ketorolac Revenue in 2024
3.5 Global Key Players of Ketorolac Head office and Area Served
3.6 Global Key Players of Ketorolac, Product and Application
3.7 Global Key Players of Ketorolac, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ketorolac Breakdown Data by Type
4.1 Global Ketorolac Historic Market Size by Type (2020-2025)
4.2 Global Ketorolac Forecasted Market Size by Type (2026-2031)
5 Ketorolac Breakdown Data by Application
5.1 Global Ketorolac Historic Market Size by Application (2020-2025)
5.2 Global Ketorolac Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Ketorolac Market Size (2020-2031)
6.2 North America Ketorolac Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Ketorolac Market Size by Country (2020-2025)
6.4 North America Ketorolac Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ketorolac Market Size (2020-2031)
7.2 Europe Ketorolac Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Ketorolac Market Size by Country (2020-2025)
7.4 Europe Ketorolac Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ketorolac Market Size (2020-2031)
8.2 Asia-Pacific Ketorolac Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Ketorolac Market Size by Region (2020-2025)
8.4 Asia-Pacific Ketorolac Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ketorolac Market Size (2020-2031)
9.2 Latin America Ketorolac Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Ketorolac Market Size by Country (2020-2025)
9.4 Latin America Ketorolac Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ketorolac Market Size (2020-2031)
10.2 Middle East & Africa Ketorolac Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Ketorolac Market Size by Country (2020-2025)
10.4 Middle East & Africa Ketorolac Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Ketorolac Introduction
11.1.4 Pfizer Revenue in Ketorolac Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Femina Pharma
11.2.1 Femina Pharma Company Details
11.2.2 Femina Pharma Business Overview
11.2.3 Femina Pharma Ketorolac Introduction
11.2.4 Femina Pharma Revenue in Ketorolac Business (2020-2025)
11.2.5 Femina Pharma Recent Development
11.3 Fuisz Pharma
11.3.1 Fuisz Pharma Company Details
11.3.2 Fuisz Pharma Business Overview
11.3.3 Fuisz Pharma Ketorolac Introduction
11.3.4 Fuisz Pharma Revenue in Ketorolac Business (2020-2025)
11.3.5 Fuisz Pharma Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Ketorolac Introduction
11.4.4 Allergan Revenue in Ketorolac Business (2020-2025)
11.4.5 Allergan Recent Development
11.5 Technical Chemicals & Products
11.5.1 Technical Chemicals & Products Company Details
11.5.2 Technical Chemicals & Products Business Overview
11.5.3 Technical Chemicals & Products Ketorolac Introduction
11.5.4 Technical Chemicals & Products Revenue in Ketorolac Business (2020-2025)
11.5.5 Technical Chemicals & Products Recent Development
11.6 Apotex Corporation
11.6.1 Apotex Corporation Company Details
11.6.2 Apotex Corporation Business Overview
11.6.3 Apotex Corporation Ketorolac Introduction
11.6.4 Apotex Corporation Revenue in Ketorolac Business (2020-2025)
11.6.5 Apotex Corporation Recent Development
11.7 Sichuan Meida Kangjiale Pharmaceutical
11.7.1 Sichuan Meida Kangjiale Pharmaceutical Company Details
11.7.2 Sichuan Meida Kangjiale Pharmaceutical Business Overview
11.7.3 Sichuan Meida Kangjiale Pharmaceutical Ketorolac Introduction
11.7.4 Sichuan Meida Kangjiale Pharmaceutical Revenue in Ketorolac Business (2020-2025)
11.7.5 Sichuan Meida Kangjiale Pharmaceutical Recent Development
11.8 Tianjin Hongri Pharmaceutical
11.8.1 Tianjin Hongri Pharmaceutical Company Details
11.8.2 Tianjin Hongri Pharmaceutical Business Overview
11.8.3 Tianjin Hongri Pharmaceutical Ketorolac Introduction
11.8.4 Tianjin Hongri Pharmaceutical Revenue in Ketorolac Business (2020-2025)
11.8.5 Tianjin Hongri Pharmaceutical Recent Development
11.9 Shandong New Era Pharmaceutical
11.9.1 Shandong New Era Pharmaceutical Company Details
11.9.2 Shandong New Era Pharmaceutical Business Overview
11.9.3 Shandong New Era Pharmaceutical Ketorolac Introduction
11.9.4 Shandong New Era Pharmaceutical Revenue in Ketorolac Business (2020-2025)
11.9.5 Shandong New Era Pharmaceutical Recent Development
11.10 Chengdu Better Pharmaceutical
11.10.1 Chengdu Better Pharmaceutical Company Details
11.10.2 Chengdu Better Pharmaceutical Business Overview
11.10.3 Chengdu Better Pharmaceutical Ketorolac Introduction
11.10.4 Chengdu Better Pharmaceutical Revenue in Ketorolac Business (2020-2025)
11.10.5 Chengdu Better Pharmaceutical Recent Development
11.11 Yongxin Pharmaceutical Industry
11.11.1 Yongxin Pharmaceutical Industry Company Details
11.11.2 Yongxin Pharmaceutical Industry Business Overview
11.11.3 Yongxin Pharmaceutical Industry Ketorolac Introduction
11.11.4 Yongxin Pharmaceutical Industry Revenue in Ketorolac Business (2020-2025)
11.11.5 Yongxin Pharmaceutical Industry Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Femina Pharma
Fuisz Pharma
Allergan plc
Technical Chemicals & Products
Apotex Corporation
Sichuan Meida Kangjiale Pharmaceutical
Tianjin Hongri Pharmaceutical
Shandong New Era Pharmaceutical
Chengdu Better Pharmaceutical
Yongxin Pharmaceutical Industry
Technical Chemicals & Products
List of Tables
 Table 1. Global Ketorolac Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tablets
 Table 3. Key Players of Injection
 Table 4. Key Players of Eye Drops
 Table 5. Key Players of Capsule
 Table 6. Global Ketorolac Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Ketorolac Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Ketorolac Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Ketorolac Market Share by Region (2020-2025)
 Table 10. Global Ketorolac Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Ketorolac Market Share by Region (2026-2031)
 Table 12. Ketorolac Market Trends
 Table 13. Ketorolac Market Drivers
 Table 14. Ketorolac Market Challenges
 Table 15. Ketorolac Market Restraints
 Table 16. Global Ketorolac Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Ketorolac Market Share by Players (2020-2025)
 Table 18. Global Top Ketorolac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac as of 2024)
 Table 19. Ranking of Global Top Ketorolac Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Ketorolac Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Ketorolac, Headquarters and Area Served
 Table 22. Global Key Players of Ketorolac, Product and Application
 Table 23. Global Key Players of Ketorolac, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Ketorolac Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Ketorolac Revenue Market Share by Type (2020-2025)
 Table 27. Global Ketorolac Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Ketorolac Revenue Market Share by Type (2026-2031)
 Table 29. Global Ketorolac Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Ketorolac Revenue Market Share by Application (2020-2025)
 Table 31. Global Ketorolac Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Ketorolac Revenue Market Share by Application (2026-2031)
 Table 33. North America Ketorolac Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Ketorolac Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Ketorolac Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Ketorolac Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Ketorolac Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Ketorolac Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Ketorolac Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Ketorolac Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Ketorolac Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Ketorolac Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Ketorolac Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Ketorolac Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Ketorolac Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Ketorolac Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Ketorolac Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Pfizer Company Details
 Table 49. Pfizer Business Overview
 Table 50. Pfizer Ketorolac Product
 Table 51. Pfizer Revenue in Ketorolac Business (2020-2025) & (US$ Million)
 Table 52. Pfizer Recent Development
 Table 53. Femina Pharma Company Details
 Table 54. Femina Pharma Business Overview
 Table 55. Femina Pharma Ketorolac Product
 Table 56. Femina Pharma Revenue in Ketorolac Business (2020-2025) & (US$ Million)
 Table 57. Femina Pharma Recent Development
 Table 58. Fuisz Pharma Company Details
 Table 59. Fuisz Pharma Business Overview
 Table 60. Fuisz Pharma Ketorolac Product
 Table 61. Fuisz Pharma Revenue in Ketorolac Business (2020-2025) & (US$ Million)
 Table 62. Fuisz Pharma Recent Development
 Table 63. Allergan Company Details
 Table 64. Allergan Business Overview
 Table 65. Allergan Ketorolac Product
 Table 66. Allergan Revenue in Ketorolac Business (2020-2025) & (US$ Million)
 Table 67. Allergan Recent Development
 Table 68. Technical Chemicals & Products Company Details
 Table 69. Technical Chemicals & Products Business Overview
 Table 70. Technical Chemicals & Products Ketorolac Product
 Table 71. Technical Chemicals & Products Revenue in Ketorolac Business (2020-2025) & (US$ Million)
 Table 72. Technical Chemicals & Products Recent Development
 Table 73. Apotex Corporation Company Details
 Table 74. Apotex Corporation Business Overview
 Table 75. Apotex Corporation Ketorolac Product
 Table 76. Apotex Corporation Revenue in Ketorolac Business (2020-2025) & (US$ Million)
 Table 77. Apotex Corporation Recent Development
 Table 78. Sichuan Meida Kangjiale Pharmaceutical Company Details
 Table 79. Sichuan Meida Kangjiale Pharmaceutical Business Overview
 Table 80. Sichuan Meida Kangjiale Pharmaceutical Ketorolac Product
 Table 81. Sichuan Meida Kangjiale Pharmaceutical Revenue in Ketorolac Business (2020-2025) & (US$ Million)
 Table 82. Sichuan Meida Kangjiale Pharmaceutical Recent Development
 Table 83. Tianjin Hongri Pharmaceutical Company Details
 Table 84. Tianjin Hongri Pharmaceutical Business Overview
 Table 85. Tianjin Hongri Pharmaceutical Ketorolac Product
 Table 86. Tianjin Hongri Pharmaceutical Revenue in Ketorolac Business (2020-2025) & (US$ Million)
 Table 87. Tianjin Hongri Pharmaceutical Recent Development
 Table 88. Shandong New Era Pharmaceutical Company Details
 Table 89. Shandong New Era Pharmaceutical Business Overview
 Table 90. Shandong New Era Pharmaceutical Ketorolac Product
 Table 91. Shandong New Era Pharmaceutical Revenue in Ketorolac Business (2020-2025) & (US$ Million)
 Table 92. Shandong New Era Pharmaceutical Recent Development
 Table 93. Chengdu Better Pharmaceutical Company Details
 Table 94. Chengdu Better Pharmaceutical Business Overview
 Table 95. Chengdu Better Pharmaceutical Ketorolac Product
 Table 96. Chengdu Better Pharmaceutical Revenue in Ketorolac Business (2020-2025) & (US$ Million)
 Table 97. Chengdu Better Pharmaceutical Recent Development
 Table 98. Yongxin Pharmaceutical Industry Company Details
 Table 99. Yongxin Pharmaceutical Industry Business Overview
 Table 100. Yongxin Pharmaceutical Industry Ketorolac Product
 Table 101. Yongxin Pharmaceutical Industry Revenue in Ketorolac Business (2020-2025) & (US$ Million)
 Table 102. Yongxin Pharmaceutical Industry Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Ketorolac Picture
 Figure 2. Global Ketorolac Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ketorolac Market Share by Type: 2024 VS 2031
 Figure 4. Tablets Features
 Figure 5. Injection Features
 Figure 6. Eye Drops Features
 Figure 7. Capsule Features
 Figure 8. Global Ketorolac Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Ketorolac Market Share by Application: 2024 VS 2031
 Figure 10. Postoperative Pain Case Studies
 Figure 11. Acute Renal Colic Case Studies
 Figure 12. Biliary Colic Case Studies
 Figure 13. Toothache Case Studies
 Figure 14. And The Pain Case Studies
 Figure 15. Trigeminal Neuralgia Case Studies
 Figure 16. Cancer Visceral Pain Case Studies
 Figure 17. Seasonal Allergic Conjunctivitis Case Studies
 Figure 18. Other Case Studies
 Figure 19. Ketorolac Report Years Considered
 Figure 20. Global Ketorolac Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 21. Global Ketorolac Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 22. Global Ketorolac Market Share by Region: 2024 VS 2031
 Figure 23. Global Ketorolac Market Share by Players in 2024
 Figure 24. Global Top Ketorolac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac as of 2024)
 Figure 25. The Top 10 and 5 Players Market Share by Ketorolac Revenue in 2024
 Figure 26. North America Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. North America Ketorolac Market Share by Country (2020-2031)
 Figure 28. United States Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Canada Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Europe Ketorolac Market Share by Country (2020-2031)
 Figure 32. Germany Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. France Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. U.K. Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Italy Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Russia Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Nordic Countries Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Ketorolac Market Share by Region (2020-2031)
 Figure 40. China Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Japan Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. South Korea Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. India Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Australia Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Latin America Ketorolac Market Share by Country (2020-2031)
 Figure 48. Mexico Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Brazil Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Middle East & Africa Ketorolac Market Share by Country (2020-2031)
 Figure 52. Turkey Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. UAE Ketorolac Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. Pfizer Revenue Growth Rate in Ketorolac Business (2020-2025)
 Figure 56. Femina Pharma Revenue Growth Rate in Ketorolac Business (2020-2025)
 Figure 57. Fuisz Pharma Revenue Growth Rate in Ketorolac Business (2020-2025)
 Figure 58. Allergan Revenue Growth Rate in Ketorolac Business (2020-2025)
 Figure 59. Technical Chemicals & Products Revenue Growth Rate in Ketorolac Business (2020-2025)
 Figure 60. Apotex Corporation Revenue Growth Rate in Ketorolac Business (2020-2025)
 Figure 61. Sichuan Meida Kangjiale Pharmaceutical Revenue Growth Rate in Ketorolac Business (2020-2025)
 Figure 62. Tianjin Hongri Pharmaceutical Revenue Growth Rate in Ketorolac Business (2020-2025)
 Figure 63. Shandong New Era Pharmaceutical Revenue Growth Rate in Ketorolac Business (2020-2025)
 Figure 64. Chengdu Better Pharmaceutical Revenue Growth Rate in Ketorolac Business (2020-2025)
 Figure 65. Yongxin Pharmaceutical Industry Revenue Growth Rate in Ketorolac Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Ketorolac Injection Market Research Report 2024
Global Ketorolac Tromethamine Market Insights Forecast to 2030
Global Ketoprofen Gel Market Research Report 2024
Global Ketorolac Tromethamine API Market Research Report 2024
Global Ketorolac Trometamol Market Research Report 2025
Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030
Global Ketoprofen Market Insights Forecast to 2030
Pharmaceutical Grade Ketorolac Tromethamine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025
Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024
Global Celecoxib Capsule Market Insights Forecast to 2030
Global Celecoxib Market Insights Forecast to 2030
Global Piroxicam Market Research Report 2024
Global Rofecoxib Market Insights Forecast to 2030
Global Pet NSAIDs Market Research Report 2025
Global Meloxicam Drugs Market Research Report 2024
Global Lornoxicam Tablets Market Research Report 2024
Global Pets NSAIDs Market Research Report 2025
Global Tenoxicam Market Research Report 2024
Global Diclofenac Potassium Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions